ArticleOncoimmunology2012

Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice.

Mariana Malvicini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.